Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jul 29;107(7):1608–1618. doi: 10.3324/haematol.2021.278853

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright© 2022 Ferrata Storti Foundation

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

PMC Copyright notice

Figure 1. — Waterfall plot for best response for evaluable patients in the phase II study by histology (n=74). Of the 93 patients in the phase II study, 8 patients did not complete 2 cycles of temsirolimus/lenalidomide (TEM/LEN) for pre-specified response assessment, 10 patients did not have reported response data, and 1 patient had Waldenström macroglobulinemia. DLBCL: diffuse large B-cell lymphoma; FL: follicular lymphoma; cHL: classical Hodgkin lymphoma; T-NHL: non-Hodgkin lymphoma; MZL: marginal zone leukemia; MCL: mantle cell lymphoma.